Bone morphogenetic protein 7 promotes resistance to immunotherapy
The mechanisms underlying resistance to immunotherapy are still poorly understood. Here, the authors show that BMP7, a molecule part of the TGF-beta superfamily, suppresses proinflammatory antitumor responses and may represent a target for overcoming resistance to PD1 inhibitors.
Guardado en:
Autores principales: | Maria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan, Jie Zhang, Ahmed I. Younes, Yue Lu, Marcos R Estecio, Hampartsoum B. Barsoumian, Hari Menon, Mauricio da Silva Caetano, Rishab Ramapriyan, Jonathan E. Schoenhals, Xiaohong Wang, Ferdinandos Skoulidis, Mark D. Wasley, George Calin, Patrick Hwu, James W. Welsh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50194472a306497690c2c253af5c1808 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy
por: Maria Angelica Cortez, et al.
Publicado: (2020) -
Joint morphogenetic cells in the adult mammalian synovium
por: Anke J. Roelofs, et al.
Publicado: (2017) -
Sustainable development through morphogenetic analysis: The case of Slovenia
por: Golob Tea, et al.
Publicado: (2021) -
Morphogenetic Protein rhBMP-2 and New Bone Formation
por: Issa,João Paulo Mardegan, et al.
Publicado: (2006) -
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
por: Neil Ghodadra, et al.
Publicado: (2008)